Danish medtech company Ellipse becomes part of a US group. The company now expects to triple the production capacity. "They really know how to churn out products from their sales channels," says CEO Jacob Kildegaard Larsen.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.